$Esperion Therapeutics (ESPR.US)$Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share. Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
Looking back at my records for 2024, I did 375 trades of single and multi contracts of sell put csp. I sold more than 1000 csp contracts for the past 12 months. I have to admit, it was quite tiring because I trade 0dte spx, swing trades, long-term investing and other option strategies aswell. But I will slow down abit for 2025, don't want to wear myself out 😃. In 2024 for my csp record, I got assigned the following stocks of 100 shares ...
12
2
1
Report
Passive Investor
:
bro..can open up your trading book.. I want to see your beautiful handwriting on your options trades
Wall Street closed in a sea of red on Wall Street after the Fed cut interest rates by 25 basis points and projected fewer interest rate cuts for 2025 amid sticky and stubborn inflation. This is the “hawkish cut” that many have talked about. The Dow Jones has declined for 10 straight days, its worst run of consecutive red days since 1974. It seems that the last path of the Fed's push to bring inflation down to its 2% target is proving more difficult than many have init...
Growth Investor27 : I own a lot & will buy more
DazzlerAus : agree but nothing seems to help
Youngman : I keep hearing nothing but good things about the stock while it goes down lol